Regulatory B cells, interleukin-10, and Atherosclerosis

Research output: Contribution to journalEditorial

5 Scopus citations
Original languageEnglish
Pages (from-to)470-471
Number of pages2
JournalCurrent Opinion in Lipidology
Volume26
Issue number5
DOIs
StatePublished - Oct 2015

Bibliographical note

Funding Information:
The authors research work was supported by a pilot grant to Hong Lu by an Institutional Development Award from the National Institute of General Medical Sciences of the National Institutes of Health under Grant number P20 GM103527-06, and an R01 (HL107319) to Alan Daugherty by National Heart, Lung, and Blood Institute of the National Institutes of Health. The content in this commentary is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

Funding

The authors research work was supported by a pilot grant to Hong Lu by an Institutional Development Award from the National Institute of General Medical Sciences of the National Institutes of Health under Grant number P20 GM103527-06, and an R01 (HL107319) to Alan Daugherty by National Heart, Lung, and Blood Institute of the National Institutes of Health. The content in this commentary is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

FundersFunder number
National Institutes of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
National Institute of General Medical SciencesR01, P20GM103527, HL107319

    ASJC Scopus subject areas

    • Endocrinology, Diabetes and Metabolism
    • Molecular Biology
    • Genetics
    • Nutrition and Dietetics
    • Cardiology and Cardiovascular Medicine
    • Cell Biology

    Fingerprint

    Dive into the research topics of 'Regulatory B cells, interleukin-10, and Atherosclerosis'. Together they form a unique fingerprint.

    Cite this